Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have known or suspected coronary artery disease (a condition affecting the heart's blood vessels) and have been referred by their doctor for diagnostic testing
- People whose heart scan (called a CCTA — a specialised CT scan of the heart) is performed using a modern, high-quality scanner (one with more than 64 slices)
Who may not be able to join:
- People who have had any non-invasive heart diagnostic test in the 90 days before enrolling in the trial
- People whose assessed risk of coronary artery disease is considered low-to-intermediate based on a specific medical scoring tool called the updated Diamond-Forrester model (confirm with trial site)
- People who are currently experiencing an acute coronary syndrome (a sudden, serious heart event such as a heart attack or unstable chest pain)
- People who are showing signs of being medically unstable at the time of enrolment
- People who have a known allergy or other reason they cannot receive contrast dye, or who have reduced kidney function
- People who are unable to hold their breath (which is required during the scan)
- People who are pregnant
- People who have irregular heart rhythms (cardiac arrhythmias)
- People who have a pacemaker or an implantable heart device (such as a defibrillator)
- People who have medical reasons preventing them from taking certain medications used during testing, including sublingual nitrates, beta-blockers, or adenosine
- People who have a structural heart muscle disease (called structural cardiomyopathy)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0258002574
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Creation of an automated integrative artificial intelligence (AI) approach for the stratification of CAD patients and assessment of vulnerable coronary plaques at risk of acute complications; Quantitative assessment of the atherosclerotic burden and high risk plaque features
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.